1. A theoretical approach for the acylation/deacylation mechanisms of avibactam in the reversible inhibition of KPC-2.
- Author
-
Lizana I, Uribe EA, and Delgado EJ
- Subjects
- Acylation, Amino Acid Sequence, Anti-Bacterial Agents pharmacology, Azabicyclo Compounds pharmacology, Catalytic Domain, Molecular Dynamics Simulation, Protein Binding, Protein Conformation, Thermodynamics, beta-Lactamase Inhibitors pharmacology, Anti-Bacterial Agents chemistry, Azabicyclo Compounds chemistry, Klebsiella pneumoniae enzymology, beta-Lactamase Inhibitors chemistry, beta-Lactamases metabolism
- Abstract
Klebsiella pneumoniae carbapenemase (KPC-2) is the most commonly encountered class A β-lactamase variant worldwide, which confer high-level resistance to most available antibiotics. In this article we address the issue by a combined approach involving molecular dynamics simulations and hybrid quantum mechanics/molecular mechanics calculations. The study contributes to improve the understanding, at molecular level, of the acylation and deacylation stages of avibactam involved in the inhibition of KPC-2. The results show that both mechanisms, acylation and deacylation, the reaction occur via the formation of a tetrahedral intermediate. The formation of this intermediate corresponds to the rate limiting stage. The activation barriers are 19.5 kcal/mol and 23.0 kcal/mol for the acylation and deacylation stages, respectively. The associated rate constants calculated, using the Eyring equation, are 1.2 × 10
-1 and 3.9 × 10-4 (s-1 ). These values allow estimating a value of 3.3 × 10-3 for the inhibition constant, in good agreement with the experimental value., (© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)- Published
- 2021
- Full Text
- View/download PDF